Infectiology · Checked.be

Summary

Conclusion

the dossier summarised in one paragraph

The computed 12-month bankruptcy probability of Infectiology is 0.7% (low). The 2022 annual accounts show equity of €11k and a net result of €8k. The company has been active since 2022 and the Belgian State Gazette contains no insolvency or warning signals.

Based on the State Gazette, CBE and 1 annual account.

Filing behaviour

From the deposit records, complete market-wide

Deadline passed, not yet counted as missing

The deadline for the year that closed on 31-12-2025 passed on 31-07-2026, 20 days ago. Our copy of the deposit register trails the National Bank (measured: median 14 days, p99 45 days), so we only call this filing missing from 45 days past the deadline.

Filed after the deadline

The financial year that closed on 31-12-2024 was due by 31-07-2025 and was filed on 29-09-2025, 60 days later. For context: 47% of the Belgian market files late and the whole 1-to-90-day band measures 2.0% abnormal legal state against a 1.66% average. We show this as a fact and do not score it.

How we compute the deadline

The year end is derived from 3 filed financial years, each closing on 31-12. The statutory deadline is seven months after the close of the financial year (art. 3:10 par. 1 CAC, art. 3:47 par. 7 for ASBL and foundations). Applied to the financial year that closed on 31-12-2024, that is 31-07-2025.

Deadline per financial year

Year closed	Due by	Filed	Variance	Reference
31-12-2025	31-07-2026	nothing on record	not filed	-
31-12-2024	31-07-2025	29-09-2025	60 d late	2025-00518723
31-12-2023	31-07-2024	31-08-2024	31 d late	2024-00446784
31-12-2022	31-07-2023	11-01-2024	164 d late	2024-00000200

Source: the National Bank's deposit records. Those records are complete, including for years whose figures we have not read yet. Filing late covers nearly half the market and is therefore not scored; only not filing, being more than 90 days late and breaking a punctual record carry weight.

Trust signals

2 signals

More than 3 years active

Founded in 2022, past the statistically most fragile first 3 years.

No legal incidents

No bankruptcy, reorganisation or interim measure in the Belgisch Staatsblad, and the KBO register records a normal legal situation.

Administrative Flags

No strikeouts found in the KBO publications we processed. That series starts in 2021 and has gaps, so this is not a confirmation that there is nothing.

Bankruptcy probability (12 mo)

Checked model v1 · free for everyone

0.7% Low

0%0,5%1,5%4%10%≥25%

Lower-failure-rate sector −Young company +Annual accounts: weaker financial profile +

Statistical estimate based on public sources, not credit advice nor a finding of fact. How do we compute this?

Financials

TurnoverNot published (abbreviated filing)

EBIT marginNot published (abbreviated filing)

Net result€8k

Working capital€1k

CSV export

Annual accounts & ratios

Source: NBB · 2022

Annual accounts filed on 29-09-2025 with the NBB · fiscal year 2024 · micro

Highlight YoY changes (±10%)

Fiscal year	2022
Deposit	micro
Revenue	-
EBITDA	€10k
Net profit	€8k
Cash flow	€8k
Staff costs	-
Income taxes	€2k
Dividends	-
Total assets	€44k
Equity	€11k
Debt	€33k
of which ≤ 1y	€33k
of which > 1y	-
Working capital	€1k
Employees (FTE)	-

Ratios (computed)

	2022
Current ratio	1.04
Quick ratio	1.04
Working capital ratio	2.8%
Solvency	24.2%
Debt / equity	3.13
Long-term debt ratio	-
Interest coverage	-
Gross margin	-
Net margin	-
ROA	17.4%
ROE	71.8%
EBITDA margin	-
Days sales outstanding	-
Days payable outstanding	-
Inventory turnover	-
Days inventory (DSI)	-

Balance-sheet composition 2022

Assets

Fixed assets €9k · 21.5% Current assets €35k · 78.6%

Equity & liabilities

Equity €11k · 24.2% Debt €33k · 75.8%

Full annual accounts (19 line items)

Filed balance sheet and income statement, exactly as deposited with the NBB.

Line item	Code	2022
Balance sheet, Assets
TOTAL ASSETS	20/58	€44k
Fixed assets	21/28	€9k
Tangible fixed assets	22/27	€9k
Current assets	29/58	€35k
Amounts receivable within one year	40/41	€32k
Cash & bank	54/58	€2k
Balance sheet, Equity & liabilities
TOTAL EQUITY & LIABILITIES	10/49	€44k
Equity	10/15	€11k
Contributions / capital	10/11	€3k
Accumulated profits (losses)	14	€8k
Amounts payable	17/49	€33k
Amounts payable within one year	42/48	€33k
Trade debts payable within one year	44	€13k
Income statement
Gross operating margin	9900	€12k
Operating result	9901	€10k
Result before taxes	9903	€10k
Income taxes	67/77	€2k
Net result for the period	9904	€8k
Result to be appropriated	9905	€8k

Ratios computed by Checked.

Health barometer

FY 2022 · computed

60 / 100 Healthy

050100

Computed from 3 of the 6 factors this model weighs. The rest cannot be derived from the filed figures, or need a prior year to compare against.

The full score breakdown, per-year score history and the indicative credit limit are in Kantoor S.

See plans →

Computed by Checked from the NBB filing for FY 2022. Indicative, not credit advice.

Structure & network

Connections & network

1 connected company

Network connections

SANTE-DIGESTION

Shared address

→

Connections derived from shared directors, addresses, shareholders and group structure in the Belgian State Gazette.

Locations & real estate

Registered office

on the map · from the address register

exact location from the address register On OpenStreetMap

9 companies at this address See who is registered here

Establishment units

1 location

Infectiology

Grand route 50, 1474 GenappeOverige gespecialiseerde wetenschappelijke en technische activiteiten

since 20222.339.256.453

Physical sites registered in the Crossroads Bank for Enterprises (CBE).

Parcels2

Ground area3,432 m²

Buildings2

Building footprint202 m²

Volume (LiDAR)2,591 m³

Tallest building20.5 m · ±6 fl.

Real-estate footprint

Source: CBE × cadastre · address linking

Parcels linked to this company through its CBE addresses (seat, establishment units, branches), cross-referenced with the cadastral parcel plan. This shows where the company operates, not a deeds register.

Wallonia 1 (50%) Brussels 1 (50%)